XML 21 R3.htm IDEA: XBRL DOCUMENT v3.25.0.1
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Dec. 31, 2024
Dec. 31, 2023
Current assets:    
Cash and cash equivalents $ 224,680 $ 243,576
Trade accounts receivable, net of allowances of $577 and $444 at December 31, 2024 and 2023, respectively 138,791 108,240
Deferred contract costs 27,958 23,508
Prepaid expenses 12,679 14,255
Other current assets 20,549 13,055
Total current assets 424,657 402,634
Equipment and leasehold improvements, net 19,321 15,184
Goodwill 882,593 887,121
Other intangible assets, net 147,823 187,891
Deferred contract costs, non-current 59,663 53,070
Other assets 46,172 43,752
Total assets 1,580,229 1,589,652
Current liabilities:    
Accounts payable 18,405 25,909
Accrued liabilities 68,363 77,447
Income taxes payable 1,014 1,248
Deferred revenue 333,573 317,546
Total current liabilities 421,355 422,150
Deferred revenue, non-current 52,136 55,886
Deferred tax liability, net 5,180 5,952
Convertible senior notes, net 369,514 366,999
Other liabilities 16,061 21,118
Total liabilities 864,246 872,105
Commitments and contingencies (Note 8)
Stockholders’ equity:    
Preferred stock, $0.001 par value, 50,000,000 shares authorized at December 31, 2024 and 2023; no shares issued and outstanding at December 31, 2024 and 2023 0 0
Common stock, $0.001 par value, 500,000,000 shares authorized at December 31, 2024 and 2023; 129,376,245 and 126,938,102 shares issued at December 31, 2024 and 2023, respectively; 129,332,030 and 126,938,102 shares outstanding at December 31, 2024 and 2023, respectively 125 126
Treasury stock, at cost; 44,215 and 0 shares at December 31, 2024 and 2023, respectively (741) 0
Additional paid‑in capital 1,269,264 1,162,993
Accumulated other comprehensive loss (30,060) (26,777)
Accumulated deficit (522,605) (418,795)
Total stockholders’ equity 715,983 717,547
Total liabilities and stockholders’ equity $ 1,580,229 $ 1,589,652